Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT™ (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old
19. Juni 2017 21:46 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, June 19, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the JMP Securities 2017 Life Sciences Conference
14. Juni 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, June 14, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at Jefferies 2017 Global Healthcare Conference
30. Mai 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, May 30, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at 2017 UBS Global Healthcare Conference
16. Mai 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, May 16, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports First Quarter 2017 Financial Results
09. Mai 2017 07:00 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017
02. Mai 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, May 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
14. März 2017 07:00 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, March 14, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host Fourth Quarter and Year-End 2016 Financial Results Conference Call on March 14, 2017
08. März 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, March 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference
28. Februar 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference
16. Februar 2017 07:30 ET
|
Neos Therapeutics, Inc
DALLAS and FORT WORTH, Texas, Feb. 16, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...